Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.0%

2 terminated out of 40 trials

Success Rate

93.3%

+6.8% vs benchmark

Late-Stage Pipeline

25%

10 trials in Phase 3/4

Results Transparency

21%

6 of 28 completed with results

Key Signals

6 with results93% success

Data Visualizations

Phase Distribution

38Total
Not Applicable (20)
Early P 1 (2)
P 1 (1)
P 2 (5)
P 3 (5)
P 4 (5)

Trial Status

Completed28
Unknown6
Terminated2
Not Yet Recruiting1
Recruiting1
Enrolling By Invitation1

Trial Success Rate

93.3%

Benchmark: 86.5%

Based on 28 completed trials

Clinical Trials (40)

Showing 20 of 20 trials
NCT07234448Not ApplicableNot Yet RecruitingPrimary

Evaluation of the Use of a Probiotic Containing Bifidobacterium Breve PRL2020 in Oral Drops in Preventing Side Effects From Amoxicillin or Amoxicillin/Clavulanic Acid Antibiotic Use

NCT06982703Not ApplicableEnrolling By InvitationPrimary

Evaluation of Butyrate Effect on Diarrhea

NCT05845073Not ApplicableCompletedPrimary

The Efficacy of a Probiotic for Antibiotic Associated Gastrointestinal Symptoms

NCT04414722Early Phase 1CompletedPrimary

Mechanisms of Probiotics and Antibiotic-Associated Diarrhea

NCT03181516Phase 2CompletedPrimary

Efficacy and Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Children on Antibiotics

NCT06665503Not ApplicableCompletedPrimary

The Impact of Zinc and Probiotics in Preventing Pediatric Antibiotic-Associated Diarrhea in Southern Iran

NCT05607056Not ApplicableCompletedPrimary

Efficacy and Safety of Sinquanon for Prevention of Antibiotic-associated Diarrhea in Adults

NCT03305627Not ApplicableCompleted

Optimized Perioperative Antibiotic Prophylaxis in Radical Cystectomy

NCT03895593Recruiting

Rescue Fecal Microbiota Transplantation for National Refractory Intestinal Infections

NCT06109740Not ApplicableCompleted

Probiotics For The Prevention of Antibiotics Associated Diarrhea in the Pediatric Intensive Care Unit

NCT05990972Not ApplicableCompleted

Clinical Study of Fecal Microbiota Transplantation in the Treatment of Antibiotic-associated Diarrhea

NCT03755765Early Phase 1CompletedPrimary

Mechanisms of Preventing Antibiotic-Associated Diarrhea and the Role for Probiotics

NCT04156555Phase 4CompletedPrimary

Antibiotic-Associated Diarrhea and the Role of Microorganisms in the Gut

NCT04171466Not ApplicableCompleted

Metagenomic and Metabolomic Reconstitution of Gut Microbiota After Broad Spectrum Antibiotic Therapy

NCT04321460Phase 3CompletedPrimary

Study of LRG-002 Hard Capsules (Lek d.d., Slovenia) Used in the Prophylaxis of Antibiotic-associated Diarrhea in Adults.

NCT03334604Not ApplicableCompletedPrimary

The Effect of a Multispecies Probiotic on Reducing the Incidence of Antibiotic-associated Diarrhoea in Children.

NCT02746198Not ApplicableCompletedPrimary

Clinical Pilot Trial on the Effect of a Probiotic Fermented Drink on Antibiotic-associated Diarrhea (AAD)

NCT02462590Phase 4Completed

Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial

NCT04212403Not ApplicableCompleted

Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB)

NCT04277156Not ApplicableUnknownPrimary

L Rhamnosus ATCC 53103 & L Reuteri DSM 29063 Compared With L Rhamnosus ATCC 53103 for Preventing AAD in Children

Scroll to load more

Research Network

Activity Timeline